Larvol Delta - Aligos-Therapeutics-Announces-Acceptance-ofLateBreaker-Oral-Presentation-of-Data-from-the-Phase-2a-HERALD-Study-of-ALG055009-in-MASH-Subjects-at-The-Liver-Meeting-TLM-2024

ALG-055009 - Aligos Therap

https://www.globenewswire.com/news-release/2024/10/15/2963289/0/en/Aligos-Therapeutics-Announces-Acceptance-of-Abstracts-on-Incremental-Data-from-ALG-000184-in-CHB-Subjects-and-Late-Breaker-Oral-Presentation-of-Data-from-the-Phase-2a-HERALD-Study-.html

Oct 15, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next